Sort
50,496 grants matching “lung cancer”
Administrative Core
$519,644Nathan J Cherrington · University Of Arizona · P30 · FY2024 · ES
Administrative Core
$519,644Nathan J Cherrington · University Of Arizona · P30 · FY2023 · ES
Regulation of Ras-Dependent Signal Transduction Pathways
$519,504Deborah K Morrison · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN: A Phase II Clinical Trial in Adolescents/Young Adults (AYA)with CNS Malignancies
$519,480Lee Roy Morgan · Dekk-Tec, Inc. · R44 · FY2019 · CA
METTL3 in chromium-induced angiogenesis and carcinogenesis
$519,475Steven B McMahon · Thomas Jefferson University · R01 · FY2022 · ES
METTL3 in chromium-induced angiogenesis and carcinogenesis
$519,475Steven B McMahon · Thomas Jefferson University · R01 · FY2023 · ES
METTL3 in chromium-induced angiogenesis and carcinogenesis
$519,475Steven B McMahon · Thomas Jefferson University · R01 · FY2024 · ES
METTL3 in chromium-induced angiogenesis and carcinogenesis
$519,475Steven B McMahon · Thomas Jefferson University · R01 · FY2025 · ES
PROTEOMICS BIOMARKER DEVELOPMENT LABORATORY
$519,390University Of Michigan At Ann Arbor · U01 · FY2000 · CA
Project 2 - Preclinical studies: Overcoming tumor heterogeneity
$519,368Steven Mark Albelda · University Of Pennsylvania · P01 · FY2018 · CA
Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes
$519,312Xifeng Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes
$519,312Xifeng Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA
CLINICAL VALIDATION OF A MIRNA BLOOD TEST TO IDENTIFY HIGH-RISK INDIVIDUALS ELIGIBLE FOR LOW-DOSE COMPUTED TOMOGRAPHY SCREENING FOR LUNG CANCER EARLY
$519,311Istituto Europeo Di Oncologia Srl · · FY2014 · Department of Defense
Nanoparticles to reprogram innate immune cells and disrupt the metastatic niche
$519,210Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2024 · EB
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis
$519,193Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Project 1: Systematic Physical and Spatial Mapping of Cancer Driver Networks
$519,167Emma Lundberg · University Of California, San Francisco · U54 · FY2024 · CA
Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models
$519,127Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Mechanism of Eukaryotic Environmental Mutagenesis
$519,111Graham C Walker · Massachusetts Institute Of Technology · R35 · FY2023 · ES
Novel approach to attenuate small cell lung cancer growth and metastasis
$519,062Mohd Wasim Nasser · University Of Nebraska Medical Center · R01 · FY2021 · CA
Novel approach to attenuate small cell lung cancer growth and metastasis
$519,062Mohd Wasim Nasser · University Of Nebraska Medical Center · R01 · FY2020 · CA
Methods for Etiologic Studies of Diet and Cancer
$519,038Arthur Schatzkin · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Building upon a tradition of excellence. The NCTN at Indiana University
$519,002Kathy D Miller · Indiana University Indianapolis · U10 · FY2017 · CA
Mechanisms of resistance to ponatinib therapy in chronic myeloid leukemia
$518,975Thomas J. O'Hare · University Of Utah · R01 · FY2017 · CA
Fabrication and Testing of a Novel PET insert for Simultaneous PET/MRI
$518,972Stuart S Berr · University Of Virginia · R01 · FY2023 · EB
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
$518,916Stephen S Hecht · University Of Minnesota · R37 · FY2010 · CA